发明名称 CARCINOSTATIC MEDICAL COMPOSITION
摘要 PURPOSE:A stabilized medical composition that is prepared by adding a peripheral vasodilator and a phospholipid to a carcinostatic agent, thus improving absorption of the carcinostatic agent and showing high directivity of the agent toward tumor cells in tissues. CONSTITUTION:A carcinostatic agent such as fluorouracil, tegafur, UFT, estracyt is combined with about 10-100wt%, based on the carcinostatic agent, of a peripheral vasodilator such as nicotinic acid, its esters, beta-butoxyethyl ester, nicmetate, bamethan sulfate, or cyclandelate and 10-300wt% of a phospholipid such as phosphatidyl choline, soybean lecithin, yolk lecithin. Thus, the absorption of the carcinostatic agent is improved, further, the agent can be brought to the tumor cells specifically, and satisfactory effect is manifested with a reduced dose with reduced side-effects.
申请公布号 JPS61189214(A) 申请公布日期 1986.08.22
申请号 JP19850028952 申请日期 1985.02.15
申请人 NAKANISHI MICHIO;AKIYOSHI MASATAKA 发明人 KIMOTO HISANORI
分类号 A61K47/24;A61K9/00;A61K9/02;A61K9/70;A61K47/00;A61P9/08;A61P35/00 主分类号 A61K47/24
代理机构 代理人
主权项
地址